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Abstract

Author Manuscript

Recent studies show a substantial incidence of Pneumocystis jirovecii colonization and infection in
patients with chronic inflammatory lung conditions. However, little is known about the impact of
Pneumocystis upon the regulation of pulmonary immunity. We demonstrate here that
Pneumocystis polarizes macrophages towards an alternatively activated macrophage-like
phenotype. Genetically engineered mice that lack the ability to signal through IL-4 and IL-13 were
used to show that Pneumocystis alternative macrophage activation is dependent upon signaling
through these cytokines. To determine whether Pneumocystis-induced macrophage polarization
would impact subsequent immune responses, we infected mice with Pneumocystis and then
challenged them with Pseudomonas aeruginosa 14 days later. In co-infected animals, a higher
proportion of macrophages in the alveolar and interstitial spaces expressed both classical and
alternatively activated markers and produced the regulatory cytokines TGFβ and IL-10, as well as
higher arginase levels than in mice infected with P. aeruginosa alone. Our results suggest that
Pneumocystis reprograms the overall macrophage repertoire in the lung to that of a more
alternatively-activated setpoint, thereby altering subsequent immune responses. These data may
help to explain the association between Pneumocystis infection and decline in pulmonary function.
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1. Introduction

Author Manuscript

Pneumocystis jiroveci is an opportunistic fungal pathogen that often causes pneumonia in
immunocompromised patients. Recently it was recognized that colonization with
Pneumocystis is associated with a decline in pulmonary function in smokers and patients
with severe forms of chronic obstructive pulmonary disease (COPD) (Morris et al., 2000;
Morris et al., 2004b; Morris et al., 2008a) as well as cystic fibrosis (CF) (Calderon et al.,
2010; Friaza et al., 2010; Sing et al., 2001). In addition to colonization and infection with
multiple microorganisms, these patients have the hallmarks of chronic lung diseases (airway
inflammation, airway remodeling, and parenchymal damage). This creates a complex
microenvironment that complicates our understanding of the role of microbes during the
development of pulmonary damage and repair. It is unknown whether the presence of
Pneumocystis alters the homeostatic set point of immune activation, nor how this influences
subsequent pulmonary insults.

Author Manuscript

Macrophages play a key role in the clearance of Pneumocystis infection (Ezekowitz et al.,
1991; Limper et al., 1997; Masur et al., 1978; O’Riordan et al., 1995). They account for the
majority of inflammatory cells recovered in bronchoalveolar lavage (BAL) samples from
COPD patients and are localized to sites of alveolar destruction. The influence of specific
macrophage characteristics on other immune cell types during pulmonary infection with
Pneumocystis are poorly understood. Macrophages have been described along a continuum
of gene expression patterns and functional status (Mantovani et al., 2002; Montaner et al.,
1999; Nelms et al., 1999; Stout et al., 2004). In contrast to the classical activation of
macrophages (CAM) induced by Th1 cytokines to an inflammatory effector cell that utilizes
reactive oxygen species for pathogen elimination (Mantovani et al., 2002; Munder et al.,
1998), alternatively-activated macrophages (AAM) not only orchestrate inflammation during
Th2-type responses, but also play a role in the regulation of inflammation and the
coordination of extracellular matrix protein production responsible for tissue remodeling and
repair (Gordon, 2003). AAMs demonstrate marked up-regulation of mannose receptor (MR),
CD23, and arginase 1, the latter of which is thought to be responsible for inhibition of CAM
responses in mice (Bansal et al., 2003; El Kasmi et al., 2008; Herbert et al., 2004; Herbert et
al., 2010). The role of alternative macrophage activation during Pneumocystis infection and
colonization is unknown and represents an opportunity to better understand the role of
Pneumocystis colonization in patients with chronic lung diseases.

Author Manuscript

Evidence suggests that alternative macrophage activation plays a role in the pathogenesis of
COPD and CF and could have significant implications in the evolution of inflammation and
pulmonary remodeling in this setting (El Kasmi et al., 2008; Pesce et al., 2009a; Pesce et al.,
2009b; Wilson et al., 2009; Wynn et al., 2010). Our previous work found that immune
responses to acute bacterial pneumonia can be altered by manipulating alternative
macrophage activation. Induction of an AAM-like phenotype in a mouse model of
Pseudomonas pulmonary infection causes a blunted neutrophil influx and decreased
peribronchiolar inflammation (Feola et al., 2010). The induction of arginase 1 expression in
these mice infected with Pseudomonas, as well as in other models of infection including
Schistosoma mansoni, appears to be protective through the suppression of excessive
inflammation (Feola et al., 2010; Pesce et al., 2009a). Although much is known of the
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function of arginase in the coordination of remodeling and repair, several studies have also
investigated its role in the inflammatory response to pathogens that elicit both Th1- and Th2type responses. With Th1-dominant infections, Arg1 expression counters effective responses
by suppressing NO production, as shown in mouse models of Mycobacterium species and
Toxoplasoma gondii infection (El Kasmi et al., 2008). Conversely however, in the Th2dominant response to Schistosoma mansoni, macrophage-specific expression of arginase-1
regulates the pathologic aspects of Th2-driven inflammation and fibrosis (Herbert et al.,
2004; Pesce et al., 2009b).

Author Manuscript

Here, we demonstrate that Pneumocystis infection induces characteristics of alternative
macrophage activation both in vitro and in vivo. We also show that the Pneumocystisinduced AAM phenotype persists and alters the immune response to a secondary bacterial
challenge. Additional studies in IL-4Rα−/− mice suggest that Pneumocystis-mediated
macrophage polarization is, to an extent, dependent upon IL-4 and/or IL-13 signaling,
although this absence does not alter the kinetics of Pneumocystis clearance in these mice.
These studies provide evidence for immune modulation as a result of colonization or
infection with Pneumocystis that may influence the progression of pathology associated with
chronic lung diseases.

2. Materials and Methods
2.1. Mice

Author Manuscript

Five- to 8-wk-old C57BL/6, BALB/c, and BALB/c-Il4ratCAMSz/J (IL-4Rα−/−) mice were
obtained from Jackson Laboratories, bred, and maintained at the AALAC accredited
University of Kentucky Animal Facility. The IL-4Rα−/− mouse is homozygous for the
Il4ratCAMSz targeted mutation. IL-4Rα is a common chain that is present in IL-4 and IL-13
receptors and is required for transmitting signals for both cytokines (Kondo et al., 1993;
Russell et al., 1993). These mice are unable to respond to IL-4/IL-13 to induce alternative
macrophage activation. Mice were housed in pathogen-free isolation, given food and water
ad libitum, and transferred to a biosafety housing unit after infection. Pneumocystis was
maintained in a colony of Rag1−/− mice as a source for all infections. All experimental
animal studies were approved by the University of Kentucky Institutional Animal Care and
Use Committee and were conducted in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals.
2.2. Enumeration of inoculated Pneumocystis organisms

Author Manuscript

To prepare Pneumocystis for inoculation, lungs removed from infected Rag1−/− mice were
pushed through a stainless steel mesh and collected in HBSS. Debris was removed by
centrifugation, and aliquots of lung homogenates were spun onto glass slides, fixed with
methanol, stained using DiffQuik (Siemens, Germany) reagents, and the number of
Pneumocystis nuclei were counted. To infect mice, animals were anesthetized lightly with
isoflurane gas, and 105 to 107 Pneumocystis nuclei, depending upon the experiment, were
injected intratracheally (i.t.) in 100µl of PBS. For detection of Pneumocystis burden, the
right lung lobes of each animal were excised, minced, and digested in RPMI 1640
supplemented with 2% fetal calf serum, 1 mg/ml collagenase A, and 50 U/ml DNase.
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Digested fractions were pushed through mesh screens, and aliquots were spun onto glass
slides and stained with Diff-Quik for microscopic enumeration. Lung burden is expressed as
log10 Pneumocystis nuclei per animal with a lower limit of detection of log10 3.23.
2.3. Infection with P. aeruginosa

Author Manuscript

The clinical mucoid strain P. aeruginosa M57-15, a gift from Anna Van Heeckeren, PhD,
Case Western University, was used in these experiments. The bacteria were grown in
trypticase soy broth (TSB) to late log phase or early stationary phase. The method for
incorporation of the bacteria into agarose beads, essential to induce prolonged infection in
mice, was adapted from previously described methods (Nacucchio et al., 1984; van
Heeckeren et al., 2002). P. aeruginosa-laden agarose beads were diluted to achieve an
inoculum of 1 to 2x105 CFU per 100µl, which is approximately the lethal dose 10 percent
(LD10). Fourteen days after Pneumocystis inoculation as described above, P. aeruginosaladen beads were instilled intratracheally using a blunted 24-gauge curved inoculation
needle while the animals were under isofluorane anesthesia. To confirm the actual inocula
given, an aliquot of the bead preparation was homogenized and plated on Pseudomonas
selection agar immediately after infection and counted after overnight incubation.
Mice were humanely euthanized on day 0 prior to infection with P. aeruginosa and on
postinfection days 3 and 10. Bronchial alveolar lavage and lung digest samples were
obtained as described above. An aliquot was plated to assess bacterial burden by manual
CFU counting on Pseudomonas selection agar. This agar was used to avoid contamination
from upper airway flora. We have verified that the lavage procedure does not significantly
affect bacterial counts of homogenized lung tissue.

Author Manuscript

2.4. Isolation of macrophages from alveolar space and lung interstitium
Mice were humanely euthanized by exsanguination under deep anesthesia. The lungs were
lavaged with 1ml aliquots of HBSS containing 3mM EDTA. Lungs were then removed and
digested in medium as discussed above. After removing an aliquot for enumeration of
Pneumocystis organisms, lung fragments were then filtered and red blood cells lysed in a
hypotonic solution and analyzed as lung interstitium. Single cell suspensions of lavaged cells
and lung digest were washed and counted.
2.5. In vitro experiments

Author Manuscript

Both an immortalized macrophage cell line and primary macrophages were utilized. Primary
bone marrow and alveolar macrophages were harvested from naïve BALB/c and IL-4Rα−/−
mice. To obtain alveolar macrophages, lungs were lavaged as described above. Primary bone
marrow macrophages were harvested after isolation of femurs and tibias by inserting a 26
gauge needle into the marrow and flushing with RPMI containing 5% FBS and penicillin/
streptomycin. The J774A.1 cell line, an immortalized macrophage cell line obtained from
adult BALB/c mice, was purchased from ATCC (Manassas, VA) (Ralph et al., 1975). The
macrophages were plated in 24-well plates at 2x105 cells/well in RPMI (Invitrogen)
supplemented with 5% FBS, β-mercaptoethanol (500µM), and penicillin/streptomycin
(10000 Units/ml, 10000µg/ml). Cells were stimulated with IL-4 and IL-13 (10ng/ml) plus
LPS (50ng/ml), LPS alone, Pneumocystis organisms at a multiplicity of infection (MOI) of
Immunobiology. Author manuscript; available in PMC 2018 February 01.
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10, or media alone. At 4h and 24h post-stimulation timepoints, cells were washed, harvested,
and counted. Separate aliquots of cells were either stained for flow cytometry or preserved
for protein or mRNA analyses.
2.6. Flow cytometric analysis of immune cell populations

Author Manuscript

Lung lavage and lung digest cells were washed in PBS containing 0.1% BSA and 0.02%
sodium azide and stained with appropriate concentrations of fluorochrome-conjugated
antibodies specific for murine CD11b, CD11c, Gr-1/Ly6G, MR, CD23, FIZZ-1, or CCR7.
Antibodies were purchased from eBioscience (San Diego, CA) or BD Biosciences (San Jose,
CA). Surface expression was determined by multiparameter flow cytometry using a
FACSCalibur cytofluorimeter (BD Biosciences). For intracellular cytokine staining, 2x106
cells from each sample were incubated for 4 hours with 50ng/ml PMA and 500ng/ml
ionomycin, and in the presence of 10µg/ml brefeldin A for the final 2 hours. Cells were
surface stained for CD11b, CD11c, and GR-1 and fixed in 4% formalin. Subsequently, cells
were permeabilized in 0.05% saponin, exposed to anti-CD16/32 antibody to block Fc
binding, and incubated with fluorescently labeled antibodies specific for tumor necrosis
factor (TNF)-α, transforming growth factor (TGF)-β, and interleukin (IL)-10. Cells were
washed thoroughly and resuspended in PBS for analysis. Fluorescence characteristics for at
least 50,000 events per sample were acquired using a BD LSRII Flow Cytometer System
(BD Biosciences) and analyzed with FlowJo (version 7.5.5, Treestar, Ashland, Oregon). All
analyses included isotype and single color controls.
2.7. qRT-PCR of AAM gene expression

Author Manuscript

For Arg1, Fizz1, and Ym1 mRNA analysis, lung digest cell suspensions were collected in
0.5ml Allprotect stabilization reagent (Qiagen, Valencia, CA), and stored at −80°C until
analysis. Cells were homogenized on ice, and total RNA was isolated using RNeasy kits
(Qiagen). mRNA was quantified with an ND-1000 (NanoDrop Technologies, Wilmington,
DE). Reverse transcriptase reactions were performed with 10ng of mRNA using Taqman
Reverse Transcriptase kit from Applied Biosystems (Carlsbad, CA). Quantitative real-time
PCR reactions were performed using 2ng cDNA loaded in 386-well plates using an
epMotion 5070 Automated Pipetting System (Eppendorf, Hamburg, Germany). qRT-PCR
reactions were run using TaqMan Gene Expression Assay primers (Mm00657889_m1
(Ym1); Mm00475988_m1 (Arg1); Mm00445109_m1 (Fizz1) and TaqMan Rodent GAPDH
Control Reagents) with ABI Taqman Universal PCR Master Mix on a 7500HT Fast RealTime PCR System (Applied Biosystems).
2.8. Arginase quantification

Author Manuscript

Lung digest cell preparation aliquots were pelleted and lysed with buffer containing 10mM
Tris-HCl, 0.4% (w/v) Triton-X-100, and Roche Mini-tablet Protease Inhibitor Cocktail
(Mannheim, Germany). Total protein was quantified using the bicinchoninic acid
colorimetric detection assay (Thermo Fisher Scientific) in cell lysates. The activity of
intracellular arginase was determined from lung digest cell lysates using the QuantiChrom
Arginase Assay Kit (BioAssay Systems, Haward, CA), which measures the conversion of
arginine to urea by arginase. After total protein quantification, 20µl of each sample was
incubated with arginine buffer at 37°C for 6 hours. The urea detection reagent containing
Immunobiology. Author manuscript; available in PMC 2018 February 01.
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anti-isonitrosopropiophenone was then added, and the optical density was read using a
490nm filter. Readings were standardized to either total protein or cell number against the
optical density of each sample’s control.
2.9. Statistical analysis
Differences between experimental groups were determined using 1-way or 2-way analysis of
variance (ANOVA) where appropriate. Bonferroni’s post hoc test was used when performing
all pair-wise comparisons, and Dunnett’s post hoc test was used when comparing groups to a
single control condition. Differences were considered statistically significant when p<0.05.
Analyses were performed using GraphPad Prism software package (GraphPad Software,
Inc., La Jolla, CA).

3. Results
Author Manuscript

3.1. Pneumocystis infection causes changes in murine macrophage characteristics

Author Manuscript
Author Manuscript

In the absence of underlying immunosuppression, normal BALB/c mice mount an immune
response against Pneumocystis, resulting in organism lung burdens that peak by day 8–12,
with clearance observed by day 21 post-infection (Qureshi et al., 2003b). To determine the
kinetics of macrophage polarization in these animals, normal BALB/c mice were infected
intratracheally with 107 Pneumocystis nuclei and followed for 28 days. Clearance kinetics
similar to those reported earlier were observed here (Qureshi et al., 2003a; Qureshi et al.,
2003b), with a peak of infection on day 11 and clearance by day 21 (Fig. 1A). After a
transient decrease in arginase production on day 4 post-infection, we consistently observed
an increase in the amount of arginase present in the lungs at day 11 post-infection, and these
protein levels remained elevated through day 21 despite Pneumocystis clearance from the
lungs to below the limit of detection by this timepoint (Fig. 1B). We then compared the
expression of AAM and CAM surface markers on infiltrating monocytes/macrophage
populations, designated as CD11b+GR1−, isolated from bronchoalveolar lavage or lung
digest samples by flow cytometry. For the AAM proteins MR and CD23, expression of each
was increased by Pneumocystis infection in both the alveolar space (lavage) and interstitium
(digest) (Fig. 2A and B). Expression of both proteins was significantly increased at day 28
post-infection on CD11b+GR1− cells in the lung lavage, which was beyond the time at
which the organisms were cleared. Expression of MR and CD23 on infiltrating macrophages
in the lung digest samples peaked on days 22 and 11, respectively, and returned to baseline
levels by day 28 post-infection. Expression of CCR7, used here as a marker of classical
macrophage activation, peaked at day 4 in the lung lavage, and day 11 in the lung digest.
Expression was back to baseline levels by day 22 post-infection in both lung compartments.
Taken together, results presented in Fig. 1 and 2 indicate that the macrophages adopt
characteristics of alternative activation, particularly in the alveolar space and at a time after
Pneumocystis has been cleared from the lungs.
3.2. Pneumocystis-mediated polarization towards an AAM phenotype is partially
dependent upon IL-4Rα
To gain insight into the signaling mechanisms responsible for Pneumocystis-mediated
macrophage polarization, we utilized IL-4Rα−/− mice, which lack the receptor to transduce
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IL-4 and IL-13 signaling. IL-4 and IL-13 are cytokines produced by T lymphocytes (among
others) that polarize macrophages to an alternatively-activated phenotype (Gordon, 2003).
Primary alveolar macrophages from IL-4Rα−/− and wildtype (WT) animals were stimulated
with Pneumocystis in vitro and then characterized for arginase expression after 24 hours of
incubation. While arginase activity increased in both WT and IL-4Rα−/− macrophages
exposed to Pneumocystis over baseline controls (Fig. 3A), macrophages from IL-4Rα−/−
mice exhibited a more modest up-regulation of arginase production following Pneumocystis
exposure compared to the WT and media controls. Arginase expression produced in the cells
isolated from IL-4Rα−/− mice is possibly occurring through another mechanism, as arginase
can be up-regulated through stimulation by other means, including IL-10 signaling (Bernard
et al., 2000; Corraliza et al., 1995; Modolell et al., 1995). This suggests that this response is
at least partially dependent upon IL-4Rα signaling.
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To evaluate whether this response occurs in vivo, we infected WT BALB/c and IL-4Rα−/−
mice with 107 Pneumocystis nuclei and examined macrophage characteristics at day 7 postinfection. Similar to previous observations, a robust increase in arginase concentration in
lung digest preparations was shown in WT animals infected with Pneumocystis in
comparison to uninfected controls (Fig. 4A). This increase in arginase production was
attenuated in IL-4Rα−/− mice, although the increase was still significant compared to the
uninfected group. The arginase activity in infected WT animals was approximately 5 times
greater than those in the infected knockout group (p<0.05). Similar observations were made
using gene expression analysis of total lung digest cell preparations. WT mice infected with
Pneumocystis had robust up-regulation of mRNA expression of Arg1, Fizz1, and Ym1 in
comparison to uninfected controls, but these responses were absent in IL-4Rα−/− mice (Fig.
4B). These results suggest that IL-4 and/or IL-13 signaling is necessary for Pneumocystismediated induction of AAM gene expression and arginase activity in vivo.

Author Manuscript

Next, we examined macrophage phenotype in more depth using flow cytometric analyses of
AAM marker expression in order to evaluate both resident (CD11c+) and infiltrating
(CD11b+) subsets on day 7 post-Pneumocystis infection. CD11b+Gr1− and CD11c+Gr1−
cells isolated from bronchoalveolar lavages and lung digests of Pneumocystis-infected
animals demonstrated a consistent up-regulation of the AAM marker MR in comparison to
uninfected controls (Fig. 4C). This held true in both the WT and IL-4Rα−/− strains, and in
both the CD11b+ (infiltrating) and CD11c+ (resident) subsets. By day 7 post-infection, the
number of CD11b+ cells expressing the classical macrophage activation marker CCR7 were
decreased by Pneumocystis infection in both the WT and knockout strains in the alveolar
space, but no change was observed in the lung digests in either mouse strain. The numbers
of CD11c+CCR7+ cells in the lung lavage were low at this timepoint, and not significantly
affected by the infection in either strain of mouse. In the lung digest, there was a significant
increase in the number of CD11c+ cells expressing CCR7 in the knockout animals (p<0.05),
due to low expression in the uninfected knockout animals.
Cells from infected animals also exhibited an increase in intracellular staining for IL-10 and
TGF-β (Fig. 4D). Overall there was a more robust increase in the number of cells producing
IL-10 in the WT animals. The knockout animals, in general, lacked an increase in
macrophage production of both IL-10 and TGF-β. Interestingly, the numbers of CD11b+ and
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CD11c+ cells producing TNF-α were significantly higher in the infected WT animals than in
the infected IL-4Rα−/− mice (p<0.05). Importantly, the Pneumocystis burden in the lungs of
infected WT and IL-4Rα−/− mice in each experimental replicate did not differ, as each strain
similarly cleared the fungal burden from the lungs by day 21 post-infection (Fig. 4E). Taken
together, these data suggest that AAM induction by Pneumocystis is, in large part,
dependent upon IL-4Rα signaling, however clearance of the organism is not dependent upon
it. The AAM protein that is the exception to this in our model is MR. It may be that, due to
the role of MR in responding to fungal pathogens such as Pneumocystis, its expression is
regulated by other mechanisms during this response.
3.3. Pneumocystis infection alters macrophage responses to subsequent bacterial
pneumonia

Author Manuscript
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Our data suggests that Pneumocystis infection causes alterations to macrophage
programming for a substantial time period. We next set out to determine whether these
changes could influence the response to a subsequent pulmonary infection. We have
previously published that alternative macrophage activation can alter pulmonary immune
responses to extracellular bacterial infection in a mouse model (Feola et al., 2010). To
determine the impact of Pneumocystis infection upon the immune response to secondary
bacterial pneumonia, we infected mice with P. aeruginosa incorporated into agarose beads
14 days after they had been infected with Pneumocystis. We chose this design because our
macrophage polarization data suggests that there is a prevalence of alternative macrophage
characteristics at this point (Fig. 2). In response to Pseudomonas infection, an increase in
lung arginase concentrations in animals co-infected with Pneumocystis was observed at day
3, with persistence through day 10 post-infection (Fig. 5A), although the differences
between infected groups were not statistically significant at the latter timepoint. Overall
numbers of total cells, CD11b+ cells, and CD11c+ cells in the lung digest were similar over
time among groups. We observed an increase in the number of CD11b+ cells in the alveolar
space, reflected in a significant increase in CD11b+MR+ cells at the day 0 timepoint, before
infecting with P. aeruginosa (Fig. 5B). On day 3 post-P. aeruginosa infection, the numbers of
CD11b+MR+ cells were significantly higher in the lung lavage (p<0.01) and lung digest
(p<0.01) of the mice who had previously been infected with Pneumocystis. By day 10 postinfection, MR expression on CD11b+ cells was back to baseline levels in both groups. We
also observed a simultaneous increase in the classical activation marker CD80 in animals
that had been dually infected on day 3 post-infection with P. aeruginosa (Fig. 5B).
Consistent with data from previous figures, and from studies in other disease models, these
results suggest that overall macrophage populations have increased expression of proteins
characteristic of both classical and alternative activation (Shirey et al., 2010).
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Both CD11b+ and CD11c+ subsets were examined by intracellular cytokine staining on days
3 and 10 post-P. aeruginosa infection (Fig. 5C). While there was a trend of an increase in the
number of cells producing the pro-inflammatory cytokine TNF-α in the dually infected
mice, differences between groups were not statistically significant due to a large amount of
variability (effect over time p=0.154 by 2-way ANOVA). The number of CD11b+ cells
producing TGF-β trended towards a significant increase in the dually infected group on both
day 3 and day 10 post infection. The difference in CD11c+ cell production of TGF-β was
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significantly higher in the dual infection group on day 3, as shown in Fig. 5D. The number
of cells producing IL-10 was also increased in the mice previously infected with
Pneumocystis, most notably in the CD11c+ subset. However, this increase was not
statistically significant. These data confirm that Pneumocystis infection alters the set-point
of macrophage activation, most notably in the more regulatory cytokines TGF-β and IL-10,
which lead to an alteration in response to the subsequent bacterial infection. It is important
to note here that some cells in the CD11c+ subset are likely dendritic cells, which also can
produce IL-10.
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Clearance kinetics are shown for P. aeruginosa pooled across experiments in Fig. 5E. No
significant differences were found between groups. All animals in all replicates were close
to having cleared the bacteria from the lungs by day 10, regardless of treatment group. The
percentage of weight change is also shown for data pooled from these experiments (Fig. 5F).
While no differences on any individual day were significant, the overall weight curves were
different between groups (p=0.009, 2-way ANOVA), demonstrating a more severe weight
loss in the group previously infected with Pneumocystis.

4. Discussion

Author Manuscript

In this report, we show that Pneumocystis skews the population of macrophages in the lungs
to acquire an alternatively-activated phenotype. Macrophages from IL-4Rα−/− animals were
restricted in their ability to up-regulate these markers to the same extent as WT animals, and
gene expression for the AAM genes FIZZ1, arg1, and Ym1 were virtually non-existent.
Pneumocystis-induced AAM polarization persisted beyond clearance of the organism, and
was shown to modulate a subsequent immune response to P. aeruginosa. Our results suggest
that the presence of Pneumocystis alters the overall pulmonary macrophage population, a
polarization that requires signaling through the IL-4Rα to reach its full effect, and influences
subsequent challenges to pulmonary immunity.
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Recently there has been increased recognition of Pneumocystis colonization and infection in
smokers and patients with COPD (Morris et al., 2004a; Morris et al., 2008b; Norris et al.,
2011). Because of the association of Pneumocystis and advanced fibrotic processes that
occur in these patients, we explored the hypothesis that the organism could influence the
pulmonary environment through its effect on macrophage activation. COPD is generally
thought to be a consequence of an abnormal response in the lungs to inhaled toxic particles
and gases, including cigarette smoke (Hogg et al., 2009). While all smokers display low
level inflammation in the lungs, a small subset of patients experience exacerbated responses
to environmental stimuli resulting in an amplified inflammatory response and a large scale
remodeling process that results in the lung lesions and airway obstruction that are
characteristic of COPD (Hogg et al., 1994; Wright et al., 1984). Indeed, studies indicate that
acute exacerbations of COPD are attributed to viruses, Mycoplasma, and other infectious
entities (Seemungal et al., 2001; Smith et al., 1980). A more recent report analyzing the gene
expression of 18 subjects with COPD who were colonized with Pneumocystis compared to a
group of 193 subjects who were not colonized, demonstrated that colonized patients had
upregulated IFNγ and other genes predominantly associated with Th1-polarized T
lymphocytes (Fitzpatrick et al., 2014). Our data suggests that the presence of Pneumocystis
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in these patients may cause modulation of the host immune response in the lungs, thereby
altering inflammation, airway remodeling, or both.

Author Manuscript

Alveolar macrophages play a critical role in the uptake and degradation of Pneumocystis
(Ezekowitz et al., 1991; Limper et al., 1997; Masur et al., 1978; O’Riordan et al., 1995). The
heterogeneous nature of the macrophage lineage lends difficulty to phenotypic and
functional characterization. In the first two weeks following Pneumocystis infection,
investigators have observed a greater number of IL-4 secreting CD4+ T cells in comparison
to CD4+ T cells secreting IFNγ (Nelson et al., 2011; Shellito et al., 2000). Similarly other
Th2 cytokines, IL-5 and IL-13, are elevated in the BAL between days 3 and 14 after
infection with Pneumocystis (Meissner et al., 2005; Nelson et al., 2011), and this
corresponds with robust levels of IL-10 produced early following infection (Meissner et al.,
2005). Elevated levels of these cytokines suggest that Pneumocystis infection induces an
environment that is favorable to elicit generation of AAM. Additionally, a recent study of
immune modulation using sulfasalazine demonstrates that this anti-inflammatory agent
increases Th2 and AAM polarization, which corresponds with an increase in phagocytosis
and clearance of Pneumocystis (Wang et al., 2010). Our data supports these studies, showing
that Pneumocystis induces an AAM phenotype within 4 hours of exposure in culture and
within 4 days in vivo. It is possible that polarization towards this phenotype comes at the
cost of an alteration in pulmonary immunity that can, at the very least, last for several days.

Author Manuscript

A study by Nelson et al. indicated that AAM polarization results in an enhanced clearance of
Pneumocystis (Nelson et al., 2011). In mice deficient in the myeloid Src-family tyrosine
kinases Hck, Fgr, and Lyn (Src triple knockout (TKO)), they report that the enhanced
clearance of Pneumocystis from the lungs (Nelson et al., 2009) is associated with this
strain’s heightened AAM polarization (Nelson et al., 2011). The Src TKO mice displayed
alveolar macrophages with enhanced production of FIZZ-1 and arginase 1, along with the
AAM-associated chemokines CCL17, CCL22, and IL-33. A member of the IL-1 family,
IL-33 acts in concert with IL-13 signaling through IL-4Rα to further up-regulate arginase 1,
Ym1, and MR expression on macrophages during airway inflammation (KurowskaStolarska et al., 2009). In addition, they demonstrated that treatment with exogenous IL-33
in normal C57Bl/6 mice results in up-regulation of AAM-markers in mice infected with
Pneumocystis, and enhanced the phagocytosis of the organism in vitro and its clearance
from the lungs in vivo (Nelson et al., 2011). These data support the notion that alternative
macrophage activation is likely playing a functional role in the response and clearance of
Pneumocystis.

Author Manuscript

In the current study, our work focuses instead on the effects of the organism upon
macrophage polarization during a normal response. While Nelson et. al. demonstrated
dramatic increases in AAM polarization in the experimental mouse models, their control
animals also exhibited moderate up-regulation of AAM-associated proteins, including
arginase and FIZZ-1 (Nelson et al., 2011). Comparing across studies, it appears that the
production of these proteins occurred to a higher degree on day 7 post-infection in the
BALB/c mice utilized in our work, as compared to the control strain utilized in their work
(C57Bl/6). This distinction may lie in the phenotypic differences associated with these mice
with regards to their biases in T cell polarization, with BALB/c mice more adept at Th2-type
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responses. Indeed, response to Pneumocystis includes both Th1 and Th2 subsets, with the
organism inducing a higher number of T cells to produce IL-4 than IFNγ in a normal
response (Shellito et al., 2000). A recent study from this group showed that Stat4−/− mice on
a C57Bl/6 background controlled Pneumocystis growth better than Stat4−/− mice on a
BALB/c background, which did not exhibit an AAM response (Myers et al., 2013). The
Nelson study additionally shows no difference in the production of IL-4 or IL-13 in the Src
TKO mice as compared to the normal control mice (Nelson et al., 2011), a finding that is
supported by our results that show alternative macrophage polarization to be achieved in
response to Pneumocystis infection, albeit to a lesser degree, in mice that lack functional
signaling through the IL-4 and IL-13 receptors.
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A recent study by Zhang et al. demonstrates that mice lacking in either CAM or AAM
responses still possess the ability to clear Pneumocystis (Zhang et al., 2015). By crossing
IFNγR−/− mice or IL4rα−/− mice to RAG2−/− animals, and then providing WT T cells by
adoptive transfer, they demonstrated that in the setting of immune reconstitution
inflammatory syndrome (IRIS), neither CAM or AAM were required for the clearance of
Pneumocystis. However, while all strains were able to clear the organism, mice that lacked a
CAM response (RAG2−/−/ IFNγR−/−) had increased Pneumocystis-related
immunopathologies (Zhang et al., 2015). Our results correspond with theirs in that the lack
of signaling through the IL4rα to restrict AAM responses did not impact the clearance
kinetics of the organism. There are important differences between studies, as our mice also
lack IL4rα on T cells, and in the Zhang study the mice were undergoing immune
reconstitution, which can in itself cause immunopathology (Bonham et al., 2008). Key
elements to the response in the mice that lacked IFNγR included impaired CD8+ T cell
regulatory function and elevated concentrations of IFNγ (Zhang et al., 2015). Indeed, these
results support that there is a complex balance of macrophage and T cell phenotypic
responses needed in order to produce an optimal situation of organism clearance and limited
pulmonary pathology.

Author Manuscript

Our results that show Pneumocystis infection alters the subsequent response to infection
with the extracellular Gram-negative bacterial pathogen P. aeruginosa are of significant
importance. Our previous studies demonstrate that treatment of mice with azithromycin, an
azalide antimicrobial agent that was demonstrated to induce alternative macrophage
activation in vitro (Murphy et al., 2008), increases in AAM properties by day 7 postinfection (including a significantly higher production of arginase) led to a decrease in
mortality and blunted peribronchiolar inflammation in C57Bl/6 mice infected with P.
aeruginosa (Feola et al., 2010). Therefore, because Pneumocystis can induce prolonged
alterations in the polarization set-point of alveolar and interstitial macrophages, subsequent
responses may be altered, leading to an impact on the pathology of chronic inflammatory
lung conditions. It is possible that AAM could function to control exaggerated aspects of
immune responses that accompany these conditions through a variety of mechanisms. These
include direct suppression of CAM-driven inflammatory processes, control of neutrophil
recruitment, or suppression of T lymphocyte responses (Kahnert et al., 2006; Katakura et al.,
2004; Muller et al., 2007; Weber et al., 2007; Weng et al., 2007).
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The robust up-regulation of arginase expression and activity following exposure to
Pneumocystis warrants investigation of the role of this mediator during infection. While
arginase-1 is known primarily for its role in the coordination of extracellular matrix protein
production that can result in pulmonary remodeling, it also is involved in limiting
inflammation. El Kasmi and colleagues demonstrated that in intracellular infection models
in mice lacking arginase-1 expression, NO production is enhanced, resulting in reduced
bacterial burdens and lower morbidity to both Mycobacterium species and Toxoplasma
gondii (El Kasmi et al., 2008). In contrast to these findings, macrophage-specific expression
of arginase-1 has been shown to regulate the aspects of Th2-driven pathologies such as
infection with S. mansoni (Herbert et al., 2010; Pesce et al., 2009a). Mice with macrophages
that lack Arg1 succumb to the associated Th2-driven pathology in this model of infection
(Herbert et al., 2010). In another model, AAMs were required to limit inflammatory
pathology associated with RSV infection in mice (Shirey et al., 2010). Studies showed that
TLR4-mediated RSV-associated Th1-type inflammatory cytokine production was regulated
by AAM. In addition to cytokine production, these investigators showed that RSV-infected
IL-4rα−/− mice, which lack substantial arginase-1 expression and blunted AAM responses,
displayed increased peribronchiolar inflammation (Shirey et al., 2010). These studies
demonstrate the detrimental consequences that can occur in the absence of AAM effectors.

Author Manuscript

While the production of arginase was blunted in alveolar macrophages isolated from
IL-4rα−/− mice, and expression of mRNA for the AAM-associated genes arg1, FIZZ-1, and
Ym1 were very low in these animals 7 days after being infected with Pneumocystis, arginase
protein expression was still detected, albeit at a lower level, both in vitro and in vivo. In light
of the fact that Pneumocystis burdens were not affected in the IL-4rα−/− mice, it is possible
that the lower degree of alternative macrophage activation and expression of the associated
effector proteins is enough to elicit the clearance of Pneumocystis. Importantly, the deletion
of IL-4rα on T cells could also be contributing to the reduction in arginase activation and
macrophage activation (Dewals et al., 2009). This will be the subject of future investigations.
Overall, our data suggests that the immune consequences of exposure to Pneumocystis may
not be as innocuous in immunocompetent hosts as once thought. Our studies demonstrate
that Pneumocystis has the capability to polarize primary macrophages towards an
alternatively-activated phenotype in an IL-4Rα-dependent manner. This phenomenon occurs
in a way that can influence subsequent infections and pulmonary insults. The extended
kinetics of this phenomenon warrants further examination and provides impetus for further
exploration Pneumocystis-mediated immunomodulation within the lungs of both healthy and
diseased patients.
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COPD

chronic obstructive pulmonary disease

CF

cystic fibrosis

CAM

classically activated macrophage

AAM

alternatively activated macrophage

BAL

bronchoalveolar lavage

MR

mannose receptor

CFU

colony forming unit

TSB

trypticase soy broth

EDTA

ethylenediaminetetraacetic acid

MOI

multiplicity of infection

FBS

fetal bovine serum

ANOVA

analysis of variance
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FIG 1.

Pneumocystis murina infection up-regulates production of arginase in vivo. BALB/c mice
were infected with 1x107 Pneumocystis (PC) organisms by intratrachael instillation on day 0
and euthanized at post-infection time points. (A) Pneumocystis burden was assessed over
time post-infection by microscopically counting organisms in lung digest preparations. (B)
Arginase activity in lung digest preparations was determined by measurement of the
conversion of arginine into urea and standardized to total protein.
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FIG 2.
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Pneumocystis murina infection up-regulates the surface protein expression of alternative
macrophage activation markers in vivo. Cells isolated from bronchoalveolar lavage (A) and
lung digest (B) preparations from BALB/c mice isolated over time post-infection were
enumerated and stained for cell surface expression of macrophage proteins and analyzed by
flow cytometry. After gating out lymphocytes and dead cells by forward and side scatter
characteristics, the number of cells within the CD11b+GR1− gate that exhibited upregulation of MR, CCR7, and CD23 as compared to unstained controls were reported over
time for each compartment. All graphs display mean ± SD for 3–4 mice per group per
timepoint, and results are representative of 2 experimental replicates. Values were compared
using 1-way ANOVA and Dunnett’s post-hoc analysis comparing means to that of an
uninfected control group. Statistically significant differences between treatment groups
indicated for P < 0.05 (*).

Immunobiology. Author manuscript; available in PMC 2018 February 01.

Deckman et al.

Page 19

Author Manuscript
Author Manuscript
Author Manuscript

FIG 3.

Author Manuscript

Pneumocystis induces arginase expression in vitro in a partially IL-4Rα-dependent manner.
Primary alveolar macrophages from BALB/c or IL-4Rα−/− mice were cultured in
quadruplicate in the presence of Pneumocystis (PC) organisms (MOI=10), IL-4/13+LPS, or
media only and harvested after 24 hours. Cell lysates were collected and assayed for
arginase activity as determined by measurement of the conversion of arginine into urea and
standardized to total protein. Data is presented as fold increase compared to unstained
controls for each cell type among CD11c+ cells. Means ± standard deviation are presented
and are representative of 3 separate experiments. Statistically significant differences between
treatment groups are denoted as follows: *, P < 0.05 and **, P < 0.01 as analyzed one-way
ANOVA and Bonferroni post test. Asterisks atop of bars indicate comparison to media
control condition, with differences between Pneumocystis and IL-4/13 treatments denoted
by brackets.
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Pneumocystis infection induces an AAM phenotype in vivo in an IL-4Rα-dependent
manner. Wildtype BALB/c and IL-4Rα−/− mice were infected with 1x107 Pneumocystis
(PC) nuclei by i.t. instillation and euthanized at 7 days post-infection. Cells were isolated
from the alveolar space via lung lavage, and subsequently whole lungs were digested to
create single cell suspensions. (A) Arginase activity in lung digest was determined by
measurement of the conversion of arginine into urea and standardized to total protein. (B)
mRNA was isolated from lung digest cells and reverse transcribed to cDNA. Gene
expression was quantified using qPCR to determine gene expression levels of Arg1, Fizz1,
and Ym1 genes. qPCR data was normalized to values generated in wildtype uninfected
animals and expressed as fold increase over controls. (C) Cells isolated from lung lavage and
lung digest samples were stained for surface expression of CD11b, CD11c, Gr1, MR, and
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CCR7 and analyzed by flow cytometry. Cells that were CD11b+Gr1− and CD11c+Gr1− were
gated upon, and the numbers of cells in each subset expressing CCR7 or MR were
determined in both the lung lavage and lung digest samples. (D) The number of
CD11c+Gr1− (left) and CD11b+Gr1− (right) cells producing IL-10, TGFβ, and TNFα were
measured by intracellular cytokine staining and flow cytometry. Lung digest preparations
were incubated with PMA, ionomycin, and brefeldin A as described and surface stained for
CD11b, CD11c, and Gr1. Following fixation they were subsequently stained for intracellular
up-regulation of TNFα, TGFβ, and IL-10. (E) Kinetics of PC clearance over time post
infection, expressed as PC nuclei microscopically counted in lung digest samples. Mean ±
standard deviations are reported for groups of 4 mice per strain, and are representative of 3
experimental replicates. Statistically significant differences between treatment groups at
each timepoint are denoted as follows: *, P < 0.05 by one-way ANOVA and Bonferroni post
test. Asterisk above bar represent difference compared to uninfected controls for each strain,
and asterisk above connecting line represents difference between knockout and WT strains.
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Pneumocystis infection alters macrophage responses to subsequent Pseudomonas aeruginosa
infection. Normal C57Bl/6 mice were infected with 1x107 Pneumocystis (PC) nuclei (or
sham infection) by intratrachael (i.t.) instillation and then challenged with 2x105 CFU P.
aeruginosa (PA)-laden agarose beads it. 14 days later and euthanized at subsequent
timepoints. Cells were isolated from the alveolar space via lung lavage, and whole lungs
were digested to create single cell suspensions. (A) Arginase activity in lung digest was
determined by measurement of the conversion of arginine into urea and standardized to total
protein. (B) Cells isolated from lung lavage and lung digest samples were identified as
CD11b+ and stained for MR and CD80 protein expression and analyzed by flow cytometry.
(C, D) The number of CD11b+CD11c− (panel C) and CD11b− CD11c+ (panel D) cells
producing TNFα, TGFβ, and IL-10 were measured by intracellular cytokine staining and
flow cytometry. Lung digest preparations were incubated with PMA, ionomycin, and
brefeldin A as described and surface stained for CD11b and CD11c. Following fixation they
were stained for intracellular up-regulation of TNFα, TGFβ, and IL-10. (E, F) P. aeruginosa
clearance kinetics and mouse weights are shown over time for data pooled from all
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experimental replicates. Means ± standard deviations (or SEM for P. aeruginosa CFU
values) are reported for groups of 3–4 mice per timepoint per condition (or pooled as noted),
and are representative of 2 experimental replicates. Statistically significant differences
between treatment groups at each timepoint are denoted as follows: *, P < 0.05; **, P < 0.01
by two-way ANOVA and Bonferroni post test.
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